43O Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial
| Autor: | Dang, C., Ewer, M.S., Delaloge, S., Ferrero, J-M., Colomer, R., de la Cruz Merino, L., Dadswell, K., Verrill, M., Eiger, D., Sarkar, S., de Haas, S., Restuccia, E., Swain, S.M. |
|---|---|
| Zdroj: | In Annals of Oncology May 2021 32 Supplement 2:S38-S39 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|